Keyphrases
Human Aortic Smooth muscle Cells (HASMCs)
100%
Platelet-derived Growth factor-BB (PDGF-BB)
95%
Angiotensin II (Ang II)
82%
Tyrosine Phosphorylation
70%
Protein Kinase
56%
Arylamides
55%
Thrombin
50%
Keratin
48%
GTPase-activating Protein
44%
Carboxamidines
44%
Phorbol 12-myristate 13-acetate
44%
Growth Factors
40%
Cell Proliferation
39%
Protein Tyrosine Phosphorylation
37%
Tumor Promoter
37%
CSF1R
37%
Endothelin-1 (ET-1)
35%
Mitogenesis
34%
Signaling Pathway
34%
Epidermis
33%
Activin
33%
Thiophene
33%
Complement Components
33%
Signal Transduction
33%
Vascular Smooth muscle Cells
31%
IC50
31%
Receptor Agonist
29%
NIH3T3
29%
P21Ras
28%
Mitogen
28%
Kinase Inhibitor
28%
G Protein-coupled Receptor
27%
Protein Kinase C Activation
27%
Phospholipase C
27%
Phosphoinositide Metabolism
26%
Epidermal Growth Factor
26%
Keratinocytes
26%
Mouse Epidermis
26%
Transforming Growth Factor-β
24%
Platelet-derived Growth Factor Receptor (PDGFR)
23%
Pharmacodynamic Model
22%
Basic Fibroblast Growth Factor (bFGF)
22%
Thrombin Receptor
22%
Suramin
22%
Benzodiazepinedione
22%
Tumor Cell Proliferation
22%
Orally Active
22%
Thiophene-2
22%
Urokinase Inhibitor
22%
Thrombopoietin Mimetics
22%
Neuroscience
Protein Phosphorylation
93%
Platelet-Derived Growth Factor
74%
Angiotensin II
62%
Cell Proliferation
57%
Protein Kinase C
49%
Phosphatidylinositide
48%
Guanosine Triphosphatase Activating Protein
44%
Growth Factor
43%
Receptor
38%
Vascular Smooth Muscle
37%
Thrombin
34%
Receptor Agonists
33%
Signal Transduction
33%
G Protein Coupled Receptor
33%
Mitogenesis
30%
Lecithinase
27%
Epidermal Growth Factor
26%
Metabolic Pathway
26%
Endothelin 1
26%
Vasoactive
25%
Keratinocyte
25%
Epidermal Growth Factor Receptor
25%
Cell Growth
23%
Fibroblast
23%
Focal Adhesion
22%
Thrombin Receptor
22%
Activin A
22%
Cancer Growth Factor
22%
DNA Synthesis
21%
Polypeptide
20%
Receptor Tyrosine Kinase
20%
Cell Migration
19%
Vascular Disease
19%
Platelet-Derived Growth Factor Receptor
18%
Basic Fibroblast Growth Factor
17%
In Vitro
15%
Mitogen Activated Protein Kinase 1
15%
Cyclic Adenosine Monophosphate
13%
Agonist
13%
Messenger RNA
13%
Signaling Mechanism
12%
Paxillin
12%
Inositol Phosphate
12%
Cell Signaling
11%
Angiotensin II Receptor Type 2
11%
Protein Kinases
11%
Receptor Expression
11%
Diglyceride
11%
Phosphatidylinositol
11%
Colony Stimulating Factor 1 Receptor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin II
93%
Receptor
61%
Pharmacodynamics
54%
Growth Factor
47%
12-O-Tetradecanoylphorbol-13-Acetate
44%
Protein Kinase C
40%
Thrombin
40%
Tumor Promoter
37%
Keratin
37%
IC50
35%
Activin A
33%
Complement Component C1
33%
Colony Stimulating Factor 1
33%
Thiophene
33%
Pharmacokinetics
33%
Protein Tyrosine Kinase
31%
Neoplasm
29%
Mitogenic Agent
29%
Phosphotransferase
29%
Phosphotransferase Inhibitor
27%
Endothelin 1
26%
Receptor Agonist
26%
Structure Activity Relationship
26%
Diseases
25%
Vascular Disease
24%
Restenosis
24%
Anti-Inflammatory Drug
22%
Protein P53
22%
Thrombopoietin
22%
G Protein Coupled Receptor
22%
Messenger RNA
21%
Polypeptide
20%
Arthritis
20%
Endothelin
16%
Urokinase
16%
Complement Component C1s Inhibitor
16%
Platelet Derived Growth Factor
16%
Phosphatidylinositide
15%
Normal Human
14%
Lecithinase
14%
Epidermal Growth Factor Receptor
13%
Neointima
13%
Reperfusion Injury
13%
Angioneurotic Edema
13%
Graft Rejection
13%
Atherosclerosis
13%
Phorbol Ester
13%
Cancer Growth Factor
12%
Paxillin
12%
Inositol Phosphate
12%
